Story preview

Eli Lilly-backed TRex Bio targets up to $133M in U.S. IPO

About this story

Published
Oct 6, 2026, 3:49 PM UTC

Continue reading on the publisher site for the full article.

Read on publisher →TradingView

News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee

At a glance

Coverage

Tone

Who else is covering this

Where in the world it’s covered

Coverage over time

Tone of the coverage

About the publisher

Related topics

Eli Lilly-backed TRex Bio targets up to $133M in U.S. IPO · News Atlas